BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22566872)

  • 1. TLR9 ligand induces the generation of CD20+ plasmablasts and plasma cells from CD27+ memory B-cells.
    Geffroy-Luseau A; Chiron D; Descamps G; Jégo G; Amiot M; Pellat-Deceunynck C
    Front Immunol; 2011; 2():83. PubMed ID: 22566872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting Cells.
    Ghamlouch H; Ouled-Haddou H; Guyart A; Regnier A; Trudel S; Claisse JF; Fuentes V; Royer B; Marolleau JP; Gubler B
    Front Immunol; 2014; 5():292. PubMed ID: 24982661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclasts support the survival of human plasma cells in vitro.
    Geffroy-Luseau A; Jégo G; Bataille R; Campion L; Pellat-Deceunynck C
    Int Immunol; 2008 Jun; 20(6):775-82. PubMed ID: 18397910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
    Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctions among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood.
    Quách TD; Rodríguez-Zhurbenko N; Hopkins TJ; Guo X; Hernández AM; Li W; Rothstein TL
    J Immunol; 2016 Feb; 196(3):1060-9. PubMed ID: 26740107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 is a growth factor for nonmalignant human plasmablasts.
    Jego G; Bataille R; Pellat-Deceunynck C
    Blood; 2001 Mar; 97(6):1817-22. PubMed ID: 11238125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cells, plasmablasts, and AID
    Steiniger BS; Raimer L; Ecke A; Stuck BA; Cetin Y
    Histochem Cell Biol; 2020 Jul; 154(1):55-75. PubMed ID: 32172287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells.
    Huggins J; Pellegrin T; Felgar RE; Wei C; Brown M; Zheng B; Milner EC; Bernstein SH; Sanz I; Zand MS
    Blood; 2007 Feb; 109(4):1611-9. PubMed ID: 17032927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients.
    van Dam LS; Oskam JM; Kamerling SWA; Arends EJ; Bredewold OW; Berkowska MA; van Dongen JJM; Rabelink TJ; van Kooten C; Teng YKO
    Front Immunol; 2020; 11():566732. PubMed ID: 33384685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.
    Wagner M; Poeck H; Jahrsdoerfer B; Rothenfusser S; Prell D; Bohle B; Tuma E; Giese T; Ellwart JW; Endres S; Hartmann G
    J Immunol; 2004 Jan; 172(2):954-63. PubMed ID: 14707068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
    Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
    J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD38hiCD138⁺ plasma cells can be generated in vitro from CD40-activated switched-memory B lymphocytes.
    Maïga RI; Bonnaure G; Rochette JT; Néron S
    J Immunol Res; 2014; 2014():635108. PubMed ID: 25759831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow derived long-lived plasma cell phenotypes are heterogeneous and can change in culture.
    Mujtahedi SS; Yigitbilek F; Benavides X; Merzkani MA; Ozdogan E; Abozied O; Moore NA; Park WD; Stegall MD
    Transpl Immunol; 2022 Dec; 75():101726. PubMed ID: 36183942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation.
    Jourdan M; Caraux A; Caron G; Robert N; Fiol G; Rème T; Bolloré K; Vendrell JP; Le Gallou S; Mourcin F; De Vos J; Kassambara A; Duperray C; Hose D; Fest T; Tarte K; Klein B
    J Immunol; 2011 Oct; 187(8):3931-41. PubMed ID: 21918187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool.
    Amu S; Tarkowski A; Dörner T; Bokarewa M; Brisslert M
    Scand J Immunol; 2007 Jul; 66(1):77-86. PubMed ID: 17587349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
    Krug A; Towarowski A; Britsch S; Rothenfusser S; Hornung V; Bals R; Giese T; Engelmann H; Endres S; Krieg AM; Hartmann G
    Eur J Immunol; 2001 Oct; 31(10):3026-37. PubMed ID: 11592079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation.
    Carpenter EL; Mick R; Rüter J; Vonderheide RH
    J Transl Med; 2009 Nov; 7():93. PubMed ID: 19906293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate stimulation of B cells ex vivo enhances antibody secretion and identifies tumour-reactive antibodies from cancer patients.
    Karagiannis P; Correa I; Chauhan J; Cheung A; Dominguez-Rodriguez D; Terranova-Barberio M; Harris RJ; Crescioli S; Spicer J; Bokemeyer C; Lacy KE; Karagiannis SN
    Clin Exp Immunol; 2022 Jan; 207(1):84-94. PubMed ID: 35020866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Reprogramming Commits Differentiation of Human CD27
    Torigoe M; Iwata S; Nakayamada S; Sakata K; Zhang M; Hajime M; Miyazaki Y; Narisawa M; Ishii K; Shibata H; Tanaka Y
    J Immunol; 2017 Jul; 199(2):425-434. PubMed ID: 28626065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotype of normal and myelomatous plasma-cell subsets.
    Robillard N; Wuillème S; Moreau P; Béné MC
    Front Immunol; 2014; 5():137. PubMed ID: 24744760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.